SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-306978
Filing Date
2013-07-29
Accepted
2013-07-29 14:01:29
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d552366d10q.htm 10-Q 1047103
2 EX-31.1 d552366dex311.htm EX-31.1 9452
3 EX-31.2 d552366dex312.htm EX-31.2 9478
4 EX-32.1 d552366dex321.htm EX-32.1 3399
  Complete submission text file 0001193125-13-306978.txt   13243863

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bmrn-20130630.xml EX-101.INS 1675587
6 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20130630.xsd EX-101.SCH 60728
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20130630_cal.xml EX-101.CAL 102381
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20130630_def.xml EX-101.DEF 398498
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20130630_lab.xml EX-101.LAB 496529
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20130630_pre.xml EX-101.PRE 465709
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 13992018
SIC: 2834 Pharmaceutical Preparations